AdJane dévoile sa stratégie de rappel vaccinal par voie muqueuse pour ses gammes de vaccins respiratoires de nouvelle génération

Summary

AdJane Biosciences released a white paper describing its clinically validated Nm-nOMV platform for mucosal booster vaccination in respiratory vaccine programs. The strategy outlines how the platform could add an exclusive mucosal component to existing intramuscular vaccination programs.